中国·腾博-www.tengbo9885.com|官网首发

中文
中文
为了病患而驱动的创新
Patient-first cell therapy innovation

2019
  • 0
Streamlined Low-Input Transcriptomics through EASY-RNAseq.     
J Mol Biol. 431(24):5075-5085. (PMID: 31491452)
Zhou Y., Xu H., Wu H., Yu H., Zhou P., Qiu X., Zheng Z., Chen Q., Xu F., Li G., Zhou J., Cheng G., He W., Zou L, Wan Y. (2019) 

 TCR repertoire and CDR3 motif analyses depict the role of αβ T cells in Ankylosing spondylitis.  
EBioMedicine. (19)30474-8. (*: Corresponding authors, PMCID: PMC6796593)
Zheng M., Zhang X., Zhou Y., Tang J., Han Q., Zhang Y., Ni Q., Chen G., Jia Q., Yu H., Liu S., Robins E., Jiang NJ., Wan Y.*, Li Q.-J. *, Chen Z.-N.*, Zhu P.* (2019)
03.23
2022
来源:
关键词:
相关阅读
关于腾博tengbo9885官网
研究与发展
产品及临床
新闻与媒体
招贤纳士

Copyright © 2019 腾博tengbo9885官网

粤公网安备 44011502000528号

粤ICP备20056630号 Powered by vancheer
XML 地图